LENZ Therapeutics (LENZ) Prepaid Assets (2020 - 2026)
LENZ Therapeutics (LENZ) reported Prepaid Assets of $6.1 million for Q1 2026, up 62.93% year-over-year from $3.8 million in Q1 2025, and up 5.88% quarter-over-quarter from $5.8 million in Q4 2025.
LENZ Therapeutics (LENZ) Prepaid Assets (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Prepaid Assets data on file, last reported at $6.1 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $6.1 million, up 62.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 62.93% YoY), and the FY2025 annual result was $5.8 million, up 109.16% from the prior year.
- Prepaid Assets advanced to $6.1 million in Q1 2026 per LENZ's latest filing, from $5.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.8 million in Q3 2022 and troughed at $19000.0 in Q2 2023.
- A 5-year average of $3.8 million and a median of $3.8 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets sank 99.56% in 2023, then soared 16342.11% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $3.3 million in 2022, then sank by 56.15% to $1.4 million in 2023, then jumped by 91.24% to $2.8 million in 2024, then jumped by 109.16% to $5.8 million in 2025, then grew by 5.88% to $6.1 million in 2026.
- Business Quant data shows LENZ's Prepaid Assets at $6.1 million in Q1 2026, $5.8 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.14 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 4.78 Mn |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 6.21 Mn |
| Dec 31, 2022 | 3.31 Mn |
| Sep 30, 2022 | 6.81 Mn |
| Jun 30, 2022 | 4.35 Mn |
| Mar 31, 2022 | 754,000.00 |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 6.28 Mn |
| Jun 30, 2021 | 2.64 Mn |